Targeted Gold Nanocluster-Enhanced Radiotherapy of Prostate Cancer

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim..

For over a hundred years, X-rays have been a main component of the radiotherapeutic approaches to treat cancer. Yet, to date, no radiosensitizer has been developed to selectively target prostate cancer. Gold has excellent X-ray absorptivity and is used as a radiotherapy enhancing material. In this work, ultrasmall Au25 nanoclusters (NCs) are developed for selective prostate cancer targeting, radiotherapy enhancement, and rapid clearance from the body. Targeted-Au25 NCs are rapidly and selectively taken up by prostate cancer in vitro and in vivo and also have fast renal clearance. When combined with X-ray irradiation of the targeted cancer tissues, radiotherapy is significantly enhanced. The selective targeting and rapid clearance of the nanoclusters may allow reductions in radiation dose, decreasing exposure to healthy tissue and making them highly attractive for clinical translation.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Small (Weinheim an der Bergstrasse, Germany) - 15(2019), 34 vom: 03. Aug., Seite e1900968

Sprache:

Englisch

Beteiligte Personen:

Luo, Dong [VerfasserIn]
Wang, Xinning [VerfasserIn]
Zeng, Sophia [VerfasserIn]
Ramamurthy, Gopalakrishnan [VerfasserIn]
Burda, Clemens [VerfasserIn]
Basilion, James P [VerfasserIn]

Links:

Volltext

Themen:

7440-57-5
Gold
Gold nanoclusters
Journal Article
PSMA
Prostate cancer
Radiosensitization
Research Support, N.I.H., Extramural
Targeted radiotherapy

Anmerkungen:

Date Completed 17.09.2020

Date Revised 17.09.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1002/smll.201900968

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM298788896